Oxford Immunotec receives 2014 Queen’s Award for Enterprise

23rd April 2014

Oxford University Innovation spin-out Oxford Immunotec has received a 2014 Queen’s Award for Enterprise.

The company was founded in 2002 to commercialise science originating from the University of Oxford. The Queen’s Awards are designed to recognise and encourage the achievements by businesses in the UK in the fields of innovation, international trade and sustainable development. The awards are made annually by Her Majesty The Queen and are only given for the highest levels of excellence demonstrated in each category.

Oxford Immunotec received a prestigious Queen’s Award for International Trade for Continuous Achievement, based on its substantial overseas revenue growth and commercial success over six years. From 2007 to 2012, Oxford Immunotec grew its overseas earnings by greater than 1300% through expansion into markets worldwide including the United States, Japan and China. The Company’sT-SPOT®.TB test for tuberculosis is now approved for sale in over 50 countries on five continents. The T-SPOT.TB test helps to diagnose tuberculosis infection before it has progressed to full-blown disease, allowing treatment of carriers to prevent further spread of TB infection and disease.

Read the Oxford Immunotec announcement

Press release sign up